
Group 1 - President Trump's initiative to revive nuclear plant construction in the U.S. faces significant challenges, as highlighted by The Wall Street Journal [1][5] - Centrus Energy is primarily focused on uranium enrichment for nuclear power plants and acts as a broker for enriched uranium in the U.S. market [3][4] - The demand for uranium is closely tied to the number of operational nuclear power plants, with current efforts mainly aimed at extending licenses or restarting closed reactors, rather than increasing the number of plants [4][5] Group 2 - Historical predictions of a "nuclear renaissance" have not materialized, raising skepticism about future growth in the sector [5][6] - The high costs associated with building new nuclear plants, estimated at $30 billion or more, necessitate significant changes for Centrus to validate its current stock valuation, which is 55 times next year's expected earnings [5][6] - Despite a substantial increase in stock price over the past year, Centrus remains a speculative investment, indicating potential volatility and risk for investors [6]